Royal Bank of Canada »

Denali Therapeutics shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Denali Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Denali Therapeutics held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Denali Therapeutics by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2023-12-31 $835k 39k 21.49
2023-09-30 $377k 18k 20.98
2023-06-30 $332k 11k 31.58
2022-12-31 $534k 19k 27.76
2022-09-30 $123k 4.0k 30.74
2021-06-30 $892k 11k 78.48
2021-03-31 $2.2M 38k 57.17
2020-12-31 $2.0M 24k 83.90
2020-09-30 $57k 1.6k 35.63
2020-06-30 $31k 1.3k 24.03
2020-03-31 $25k 1.4k 17.33
2019-12-31 $94k 5.3k 17.48
2019-09-30 $6.0k 400 15.00
2019-03-31 $9.2k 407 22.50
2018-12-31 $16k 786 20.83
2018-09-30 $34k 1.5k 22.16
2018-06-30 $1.0k 43 23.26
2018-03-31 $1.0k 68 14.71
2017-12-31 $16k 1.0k 16.00